Member Info for Techtonic

Leicester..

It matters not whether anyone is a "trader" or not.

Ultimately everyone is a "trader".

And those who have been hooked on the technology for years I've lost about 95% of their investment.

The technology is known - although not in the human body yet. Whether it's good enough to gain traction is the issue now

That's why there is no discussion bout the technology. It's all been said

Now is the time to deliver .

So, the long mooted £4million fundraiser finally arrives.

Not a bad price actually. Higher than expected, so I'm back in here today

Hi OAPK ..hope you're ok

Let's face it, we're going to see a fundraise at some point near/medium term, hopefully at higher price if good news has come first - but not holding my breath.

I think what will be telling is if Nigel /Alastair/Palfreyman decide to buy big in the fundraiser.

You would think they would show confidence by putting their short arms much further into their deeper pockets..

Not £5k etc - bit more like £20K+ each. Even that would be low scale.

But at least it would show confidence..

If they decide not to get involved in the fundraiser I think that would be the most telling statement they could make on future prospects.

Hi Part-time..

I'm guessing, firstly, technically it was due a bounce from 2.35p..

I think there is an upward momentum with the business direction, and I'm guessing that there is good news in the pipeline.

The company are hosting some share event to potentially attract institutional investors at the end of month.

Maybe some momentum gathering with that

Cheers all.

I'd also been confused/forgot equity stake 1.5% is a bonus

Green, Brond,Jace,long, Neil etc..

Did anyone get a definitive answer on Ciz' stake I'm Ciz Bio?

Did anyone suss out whether it's still 10% or reduced to 1.5%..

As far as I remember this point is still ambiguous.. but I may have missed something

Cheers

Davey.. yes could be an individual or individuals trying to get a momentum trade by pushing the share price up.

However, you would expect if this was part of a concerted effort it would be accompanied by ramping posts on here/Twitter, which it wasn't..

Ps..it may also get a big boost if it mentions the official USA launch..

But, I have more than a sneaking suspicion that this will be delayed - has everything is with Cizzle - past the stated April timeframe.

In fact I would be absolutely amazed if they stuck to it

Hi Joey,

It's all guesswork isn't it, but if the next news is simply the lab accreditation, then I think it will spike up (maybe 2.5 -3p) and back down again.

It depends how they word it, and if they say that this now opens up Cizzles progress into the Chinese market, then the herd will arrive with multi- billion dollar figures - and it could rapidly double or even more.

There's also a chance remember that the next news could be a damp squib. Ciz has crushed expectation in the past.

So...depends how they word it.....which is usually pretty flat , to be honest.

And from past experience, although supposedly illegal (right!), what sometimes happens is that those in the placing forward sell their shares.

Something is definitely afoot

HOMER - you read my mind!

I'm not saying this with any certainty but this has all the hallmarks of pre-fundraise.

MMs lure small retail investors in by raising the price..

There are volumous small trades, but then this allows bigger holders to sell large.

Combined with all the share talks they're doing, sniffs of a fundraise soon , to me

Please! Do not ask Joey complicated questions like "when are you out?"

Start off with simple things like "what day is it today?"

The lad patently doesn't know what the hell he's doing - apart from annoying just about every other poster on LSE 🤔🤣

"stick"

I wonder if the share price will ever stock above 3.4p..

Seems to be stuck in a perpetual trading pattern, although prospects seem good.

Amendment:

When I used the phrase the data "isn't up to scratch", I didn't mean that the data was bad. In fact it sounds like the accumulator data to date is excellent, but needs expanding for big Pharma to get onboard.

Got to say that NUVEC sounds top notch. It appears to tick all boxes..multi-load delivery, targeted delivery with high efficacy, oral delivery, easy to manufacture and load, cheap to do so, and doesn't degrade in transportation.

Incredible really. If it all falls into place..wow. the potential is mind-blowing.

Sounds like could be anything from a few months to 2026 for licensing.

I do hope there is some price -raising news to re-rate before any fundraise (which I'm expecting mid-year).

ATM we're at £2.4Million. looks like we're significantly undervalued in comparison to other similar companies.

However, can't blame the Market after the abject performance in recent years.

Ps regarding the company not informing shareholders "immediately".

I think those of us well versed in the behavior of this company know that they don't really give a monkey's about shareholders.

Communications are as poor as they get, and the company have a bad habit of not releasing negative news, only positive (apart from the stinker of a fundraiser!) , so at any given time you never quite know where you are with it. Not good

I don't subscribe to that really , Jace.

If you look at the history of the trading patterns with this share, it's entirely normal in its behaviour.

I do agree that there has been several firms that have delisted or gone private in the last year or two - leaving shareholders shafted.

I don't really think that this is having a bearing on this - yet. Although at some point in future I do think it will be so US-centric that it could happen.

Ok, I've had a good listen .

Yes, I tend to agree with the previous posters - it's a bit like nearly reaching the horizon, and then the horizon is pushed back further...

Never quite within grasp..

It's obvious that the data set is not up to scratch at the moment and needs building before licenses and partnerships.

Now, how long that takes is anyone's guess... Maybe it never quite gets there or maybe there's a point of inflection where...

Boom! It happens.

I'm quite curious as to what is going on with Dr Michael Palfreyman in the US . I should have submitted a question really.

It seems to have gone quiet over there but I'm taking it that he's having a similar role in the US as Alastair Smith has here - contacts and presenting data sets to big Pharma.

Near term inflection points of sorts..

We have the in vivo next month (March)

And also the possibility that nanogenics gets orphan drug status in early March.

Generally speaking it seems like the tech is fantastic.

It's a balance between patience maybe paying off in a huge way..many multiples , even 100s, or how long is a piece of string... And how long do you go along that process before losing faith..?

Fundraiser looks nailed-on in 2025, but at what price - hopefully after the share price has risen with the near term inflection points.

Cheers Niles.

Will have a listen now